107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands.

scientific article published in February 2003

107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0960-8966(02)00213-4
P698PubMed publication ID12565916

P50authorFrancesco MuntoniQ29645259
P2093author name stringBourke JP
Bushby K
P2860cites workMutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophyQ22009039
Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophyQ24317622
Unusual type of benign x-linked muscular dystrophyQ24519418
Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycanQ24535942
Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy.Q24539152
Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system diseaseQ28139053
Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?Q28353993
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)Q28378044
Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive ratsQ32055195
Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophyQ72586556
Cardiomyopathy in duchenne, becker, and sarcoglycanopathies: a role for coronary dysfunction?Q73066157
Pathogenesis of inherited forms of dilated cardiomyopathyQ73223944
Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophyQ73226910
Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controlsQ73637225
Cardiac abnormalities and cytosine-thymine-guanine trinucleotide repeats in myotonic dystrophyQ73739637
The phenotype of calpainopathy: diagnosis based on a multidisciplinary approachQ73739715
Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year periodQ73949073
Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat lengthQ74176906
Right ventricular MR abnormalities in myotonic dystrophy and relationship with intracardiac electrophysiologic test findings: initial resultsQ74390304
Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophyQ74529487
Steroids in muscular dystrophy: where do we stand?Q77131915
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1CQ77346768
60th ENMC International Workshop: non X-linked Emery-Dreifuss Muscular Dystrophy 5-7 June 1998, Naarden, The NetherlandsQ77376208
Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophyQ77568415
Clinical characteristics of sudden death victims in heritable (chromosome 1p1-1q1) conduction and myocardial diseaseQ77579194
Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophyQ77808613
MR Imaging of the heart with cine true fast imaging with steady-state precession: influence of spatial and temporal resolutions on left ventricular functional parametersQ77870953
Cardiac involvement in carriers of Duchenne and Becker muscular dystrophyQ78005705
Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosisQ78039379
Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilationQ78616932
Myotonic heart disease: a clinical follow-upQ33158068
Emerin and cardiomyopathy in Emery-Dreifuss muscular dystrophyQ33603986
Cardiac involvement in congenital myotonic dystrophyQ33610382
The natural history of congenital myotonic dystrophy: mortality and long term clinical aspectsQ33623147
The limb-girdle muscular dystrophies-multiple genes, multiple mechanismsQ33724091
Major beta blocker mortality trials in chronic heart failure: a critical reviewQ33780871
The cardiomyopathies: an overviewQ33866492
Electrocardiographic findings in myotonic dystrophyQ34117784
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE InvestigatorsQ34539986
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failureQ34620874
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study GroupQ34718800
The heart in limb girdle muscular dystrophy.Q35366393
Cardiac involvement in Emery Dreifuss muscular dystrophy: a case seriesQ35373093
Emery-Dreifuss muscular dystrophy: report of five cases in a family and review of the literatureQ39792724
Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophyQ41004237
Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvementQ44395107
Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophyQ47210873
Cardioprotection for Duchenne's muscular dystrophyQ48224419
Left ventricular myocardial function in myotonic dystrophy.Q51059337
Ventricular late potentials in myotonic dystrophy.Q52440069
Systemic and regional hemodynamic effects of perindopril in congestive heart failureQ54327761
Cardiac involvement in patients with myotonic dystrophy: characteristic features of magnetic resonance imagingQ57085849
Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C geneQ57640076
Evaluation of cardiac and respiratory involvement in sarcoglycanopathiesQ58052185
Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophiesQ58052218
Evaluation of the cardiomyopathy in becker muscular dystrophyQ58052228
Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker type muscular dystrophyQ58911533
Natural history of cardiac involvement in myotonic dystrophy: Correlation with CTG repeatsQ60050798
A mutation in the X-linked Emery–Dreifuss muscular dystrophy gene in a patient affected with conduction cardiomyopathyQ61978469
High Incidence of Sudden Death with Conduction System and Myocardial Disease Due to Lamins A and C Gene MutationQ63531545
Cardiac involvement in Becker muscular dystrophy.Q64896809
Sequence of cardiac changes in Duchenne muscular dystrophyQ67260188
Familial Congenital Sinus Rhythm Anomalies: Clinical and Pathological CorrelationsQ67463881
The heart in Duchenne muscular dystrophy: a non-invasive longitudinal studyQ67554298
The heart in Becker muscular dystrophy, facioscapulohumeral dystrophy, and Bethlem myopathyQ68122875
Permanent paralysis of the atrium in a patient with facioscapulohumeral muscular dystrophyQ69503608
Cerebral embolization in two young patients with fascioscapulohumeral muscular dystrophy and atrial dysrhythmiasQ69714178
Discrepancy between systolic and diastolic dysfunction of the left ventricle in patients with Duchenne muscular dystrophyQ70754430
Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophyQ71127157
Echocardiographic evaluation of left ventricular function in Duchenne's muscular dystrophyQ71286957
Cardiac dysfunction with Becker muscular dystrophyQ71517866
Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophyQ71822781
Cardiac involvement in facio-scapulo-humeral muscular dystrophy: a family study using Thallium-201 single-photon-emission-computed tomographyQ71971083
Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic studyQ72279706
P433issue2
P921main subjectNetherlandsQ55
muscular dystrophyQ1137767
P304page(s)166-172
P577publication date2003-02-01
P1433published inNeuromuscular DisordersQ1981326
P1476title107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands.
P478volume13

Reverse relations

cites work (P2860)
Q36266919A case of Becker muscular dystrophy with early manifestation of cardiomyopathy
Q87157531Absence of Cardiac Benefit with Early Combination ACE Inhibitor and Beta Blocker Treatment in mdx Mice
Q36877691Ambulatory Monitoring and Arrhythmic Outcomes in Pediatric and Adolescent Patients With Duchenne Muscular Dystrophy
Q36466464An urgent need for a change in policy revealed by a study on prenatal testing for Duchenne muscular dystrophy
Q33680612Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy
Q45242479Autosomal dominant limb-girdle muscular dystrophy associated with conduction defects (LGMD1B): a description of 8 new families with the LMNA gene mutations
Q34600310Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy
Q39010745Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?
Q30487626Cardiac assessment of patients with late stage Duchenne muscular dystrophy
Q43628283Cardiac involvement determines the prognosis of Duchenne muscular dystrophy
Q43836668Cardiac involvement in Dutch patients with sarcoglycanopathy: a cross-sectional cohort and follow-up study
Q50052366Cardiac involvement in the muscular dystrophies
Q38204281Cardiac management of ventilator-assisted individuals with Duchenne muscular dystrophy
Q36398766Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders
Q42833726Cardiac tissue velocities and strain rate in the early detection of myocardial dysfunction of asymptomatic boys with Duchenne's muscular dystrophy: relationship to clinical outcome.
Q37639933Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics
Q37889770Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions
Q37312201Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry
Q57642759Clinical and muscle biopsy findings in Norwegian paediatric patients with limb girdle muscular dystrophy 2I
Q38267714Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions
Q37552615Consensus statement on standard of care for congenital muscular dystrophies
Q36069707Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy
Q43270760Contiguous gene deletion syndrome in a female with ornithine transcarbamylase deficiency
Q33844719Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy
Q24185788Corticosteroids for the treatment of Duchenne muscular dystrophy
Q87425283Current treatment and management of dystrophinopathies
Q36949803Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy.
Q28082625Current understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophy
Q88689556DMD mutation and LTBP4 haplotype do not predict onset of left ventricular dysfunction in Duchenne muscular dystrophy
Q45281605Developing standardized corticosteroid treatment for Duchenne muscular dystrophy.
Q37105210Development of multiexon skipping antisense oligonucleotide therapy for Duchenne muscular dystrophy
Q37640907Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
Q37640910Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
Q36982543Diagnostic utility of cardiac magnetic resonance for detection of cardiac involvement in female carriers of Duchenne muscular dystrophy
Q41822348Diastolic dysfunction precedes hypoxia-induced mortality in dystrophic mice
Q87396216Dilated cardiomyopathy
Q42350965Disease-modifying effects of orally bioavailable NF-κB inhibitors in dystrophin-deficient muscle
Q43076294Duchenne muscular dystrophy: Canadian paediatric neuromuscular physicians survey.
Q28067793Duchenne muscular dystrophy: the management of scoliosis
Q44607177Duchenne/Becker muscular dystrophy in the family: have potential carriers been tested at a molecular level?
Q35606737Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials
Q37367994ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene
Q82296972Early detection of cardiomyopathy in Duchenne muscular dystrophy, is there a role for MRI?
Q42855263Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.
Q56900219Echocardiographic and Electrocardiographic Findings of Cardiomyopathy in Duchenne and Becker?Kiener Muscular Dystrophies
Q99240518Efficacy and safety of ropivacaine HCl in peribulbar anaesthesia for cataract surgery in patients with myotonic dystrophy type 1
Q24670706Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy
Q49164127Evaluation of cardiac functions in children with Duchenne Muscular Dystrophy: A prospective case-control study
Q48621814Evaluation of the North Star Ambulatory Assessment scale and cardiac abnormalities in ambulant boys with Duchenne muscular dystrophy
Q34508301Experimental models of duchenne muscular dystrophy: relationship with cardiovascular disease
Q36728102Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice
Q38085610Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations
Q38125766Genetics in dilated cardiomyopathy
Q24242199Glucocorticoid corticosteroids for Duchenne muscular dystrophy
Q24247197Glucocorticoid corticosteroids for Duchenne muscular dystrophy
Q33697703Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1.
Q41766907Heterogeneous abnormalities of in-vivo left ventricular calcium influx and function in mouse models of muscular dystrophy cardiomyopathy
Q36895785Hypoxia-induced cardiac injury in dystrophic mice
Q33970356Identification of de novo mutations of Duchénnè/Becker muscular dystrophies in southern Spain.
Q45868920Improvement of cardiac fibrosis in dystrophic mice by rAAV9-mediated microdystrophin transduction.
Q54399356Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy.
Q36861720Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
Q42950227Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy
Q35582781Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy
Q57390065Limb Girdle Muscular Dystrophies
Q54487655Manifesting carriage of a Duchenne muscular dystrophy mutation: an unusual cause of impaired lung function in CF.
Q35122156Mechanical and non-mechanical functions of Dystrophin can prevent cardiac abnormalities in Drosophila
Q86291937Muscular dystrophies
Q33917072Myocardial atrophy in children with mitochondrial disease and Duchenne muscular dystrophy.
Q37278457Myocardial late gadolinium enhancement is associated with clinical presentation in Duchenne muscular dystrophy carriers
Q36925658Myostatin does not regulate cardiac hypertrophy or fibrosis
Q64884115Myotonic dystrophy type 1 and pulmonary embolism: successful thrombus resolution with dabigatran etexilate therapy.
Q41955267Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells
Q36226880Neurology and orthopaedics
Q37910906Pathophysiology and therapy of cardiac dysfunction in Duchenne muscular dystrophy
Q47747088Prenatal diagnosis of Duchenne and Becker muscular dystrophies: Underestimated problem of the secondary prevention of monogenetic disorders
Q30626615Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice
Q27348818Quality improvement in neurology: muscular dystrophy quality measures
Q46527029Rapidly progressive heart failure requiring transplantation in muscular dystrophy: a need for frequent screening
Q42754311Recovery of systolic dysfunction in duchenne muscular dystrophy due to the point mutation c.4213C>T.
Q48005629Results of Duchenne muscular dystrophy family screening in practice: leaks rather than cascades?
Q38368957Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children
Q24621454Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy
Q34279254Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy.
Q36288840Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study
Q45384428Subepicardial dysfunction leads to global left ventricular systolic impairment in patients with limb girdle muscular dystrophy 2I.
Q37240478Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin-Deficient Hearts
Q36351131The role of the neuromuscular medicine and physiatry specialists in the multidisciplinary management of neuromuscular disease
Q51641338The screening for X-linked Emery-Dreifuss muscular dystrophy amongst young patients with idiopathic heart conduction system disease treated by a pacemaker implant.
Q37329558Therapeutic possibilities in the autosomal recessive limb-girdle muscular dystrophies
Q36304335Therapy insight: cardiovascular complications associated with muscular dystrophies
Q36227105Towards an integrative approach to the management of myotonic dystrophy type 1
Q38178061Treatment of dystrophin cardiomyopathies
Q82576866Treatment of the heart in Duchenne muscular dystrophy
Q35820608Unusual respiratory manifestations in two young adults with Duchenne muscular dystrophy
Q33408844Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy